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LABORATORY INVESTIGATION
Fish oil supplementation and essential fatty acid deficiency
reduce nitric oxide synthesis by rat macrophages
VALERIE BOUTARD, BRUNO FOUQUERAY, CAROLE PHILIPPE, JOELLE PEREZ, and Lkuw.wrBAUD
Institut National de Ia Sante et de Ia Recherche Médicale, Unite 64, HOpital Tenon, Paris, France
Fish oil supplementation and essential fatty acid deficiency reduce
nitric oxide synthesis by rat macrophages. Both fish oil-derived w-3
polyunsaturated fatty acid (w3 PUFA) supplementation and essential fatty
acid (EFA) deficiency have been shown to exert anti-inflammatory effects
and, hence, to ameliorate immune-mediated glomerulonephritis. The
mechanisms underlying these effects include alterations in the production
of eicosanoids, cytokines (that is, tumor necrosis factor, TNF-a) and
reactive oxygen species by blood borne cells, Because, in addition to these
mediators nitric oxide (NO) is also implicated in glomerular injury, we
have examined if both diets affected maerophage NO production as well.
Rats were fed a standard chow, an w3 PUFA-supplemented diet, or an
EFA-defieient diet for six weeks before resident peritoneal macrophages
were isolated. These cells were exposed to lipopolysaccharide (LPS) and
the NO metabolite, nitrite (NO2—), was measured in the medium using the
Griess reagent. Release of NO2 was enhanced by LPS in a dose-
dependent manner. With 10 ng/ml LPS challenge, NO2 release was
reduced by 37% and 57% by co3 PUFA supplementation and EFA
deficiency, respectively. NO2 returned to control levels two weeks after
the end of diet. Macrophage production of TNF-a responded in a similar
manner. Diet-induced reduction of NO2 release was neither attributable
to a reduction of inducible NO synthase mRNA levels as shown by
Northern blot analysis, nor to an increased competition of NO synthase
and arginase for the substrate (L-arginine). Indeed, arginase activity of
macrophages was even slightly reduced by both a3 PUFA-supplemented
diet and EFA-deficient diet. Diet-induced reduction of NO synthase
activity was specific for the inducible form since constitutive NO synthase
activity in vascular wall was unaffected by EFA deficiency, and even
significantly increased by w3 PUFA supplementation. These data demon-
strate that NO synthesis by rat macrophages is down-regulated by both
w3-PUFA supplemented diet and EFA-defieient diet, This may contribute
to the explanation of the anti-inflammatory effects of such dietary
treatments.
Modifications of dietary fatty acids have been shown to exert
anti-inflammatory effects and, hence, to ameliorate several animal
models of renal disease [1, 2]. Such modifications include supple-
mentation with fish oils that are rich in 03 polyunsaturated fatty
acid (w3 PUFA), particularly eicosapentaenoic acid/docosahexae-
noic acid and restriction of the essential fatty acids (EFA). The
effects of fish oil in experimental models of lupus nephritis [3, 4],
accelerated nephrotoxic serum nephritis [5], and membranous
nephropathy [61 are to delay the onset of renal disease, to
attenuate the decline in glomerular filtration rate, and to prevent
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the rise in proteinuria, respectively. Similarly, the beneficial effects
of EFA deficiency during the acute and chronic phases of
nephrotoxic serum nephritis [7, 8] and in the experimental model
of human minimal change disease [9] include limitation of gb-
merular infiltration by macrophages, improvement of glomerular
hemodynamics, and reduction of proteinuria. The mechanism by
which dietary fatty acid manipulations exert their effects in
inflammation is not clear at this time. One hypothesis is that they
reduce the synthesis of arachidonate metabolites potentially in-
volved in glomerular alterations. For example, eicosapentaenoie
acid from fish oil is converted by eyclooxygenase and lipoxygenase
pathways to thromboxane (TX) A3 and leukotriene (LT) B5,
respectively. These inflammatory and vasoconstrictive lipids are
much less active than the arachidonic acid metabolites TXA2 and
LTB4 [1]. Beside eicosanoid synthesis, fish oil supplementation
affects several other functions of cells involved in inflammation.
Replacement of arachidonic acid by eicosapentaenoic acid in the
cell membranes of neutrophils, monocytes/macrophages, or resi-
dent gbomerular and interstitial cells may reduce the formation of
platelet activating factor (PAF) [1], reactive oxygen species [10],
and cytokines, essentially interleukin-1 (IL-i) and tumor necrosis
factor alpha (TNF-cw) [ii]. Additionally, it can suppress LTB4-
and PAF-stimulated chemotaxis by reducing signal transduction
at the level of phospholipase C [12].
Macrophages infiltrating glomeruli in nephrotoxic nephritis
[13] and membranous nephropathy [14, 15] also produce L-
arginine-derived nitric oxide (NO). This metabolite is implicated
in glomerular injury since it may alter the intrinsic glomerular
cells and have hemodynamic effects [15]. We therefore investi-
gated the hypothesis that dietary fatty acid manipulations have
anti-inflammatory properties by affecting the NO synthase path-
way in maerophages as well. To this aim, we compared the effect
of w3 PUFA supplementation and EFA deficiency on the produc-
tion of nitrite (NO2—) and nitrate (NO3—), the major stable end




Male Sprague-Dawley rats were used in all experiments. From
the time of weaning, age-matched animals were fed either a
standard rat chow, a standard rat chow supplemented with 15%
menhaden oil, a rich source of w3 PUFA, or an EFA-deficient
diet. All the diets were prepared by Ets. L. Pietrement (Provins,
France). The fatty acid compositions of the lipids were analyzed
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Lauric (12:0) 0.09 — 41.72
Myristic (14:0) 2.12 5.48 17.62
Palmitic (16:0) 21.21 15.77 11.61
Palmitoleic (16.1) 2.82 13,34 0.32
Stearic (18:0) 6.79 3.48 12.39
Oleic (18:1) 24.53 25.00 2.72
Linoleic (18:2) 33.25 6.79 1.02
Lmolenic (18:3) 3.60 1.08 0.31
Arachidonic acid — — —
(20:4)
EPA (20:5) — 9.40 —
DCHA (22:6) — 0.23 —
Numbers represent percent of the total fatty acid content. Abbreviation
is DCHA, docosahexaenoic acid.
by Laboratoires des Agriculteurs de France (Paris, France) and
are listed in Table 1. The animals were maintained on these diets
for two to six weeks before the experiments were performed.
Isolation of peritoneal macrophages
Resident macrophages were obtained by peritoneal lavage with
Hank's solution (HBSS, Flow Laboratories, Irvine, UK) contain-
ing 20 IU/ml heparin. Cells were washed by centrifugation, then
resuspended in MEM (Boehringer, Mannheim, Germany) con-
taining 5% fetal bovine serum (FBS), 2 mrvi glutamine, and 100
U/ml penicillinhl00 g/ml streptomycin. They were plated at 2 X
106 cells/mi in 0.5 ml medium in 24-well culture plates (Nunc,
Roskilde, Denmark) and were allowed to adhere for two hours at
37°C in a 5% C02-95% air atmosphere. The nonadherent cells
were removed by two washings and the macrophage monolayers
were then overlaid with 0.3 ml MEM containing 1% FBS and 0 to
100 ng/ml LPS (Escherichia coli 026:B6; Sigma Chemical Co, St.
Louis, Missouri, USA). All adherent cells were stained in immu-
nofluorescence with the rat ED1 monocloned antibody (Serotec,
Oxford, UK). The concentration of L-arginine in the medium was
0.7 mrvi. At indicated times, cell-free culture supernatants were
harvested before they were assayed for N02/N03 and TNF-a
concentrations.
Determination of inducible NO synthase activity
Inducible NO synthase activity was assayed indirectly by mea-
suring NO2/N03 production. N02 was measured by a cob-
rimetric assay based on the Griess reaction, as previously de-
scribed [16], with minor modifications. Briefly, 75 .d aliquots of
macrophage-conditioned medium were incubated with 150 ,al
aliquots of Griess reagent (1% sulfanilamide/0.1% naphtylethyl-
ene diamine dihydrochloride/2.5% H3P04). The absorbance was
read at 540 nm after 15 minutes. N02 concentration was
determined with reference to a standard curve by using concen-
trations from 1.5 to 50 pxi sodium nitrite in culture media. In
some selected cases, N03 concentration was also measured after
reduction of N03 to N02 with nitrate reductase [17].
TNF-a assay
TNF-a biological activity was determined by the assay for
cytotoxicity using L-929 cells as previously described [18]. Speci-
ficity for TNF-a was demonstrated by neutralization of TNF-a-
induced cytotoxicity with anti-mouse TNF-a (106 neutralizing
U/ml, Genzyme, Cambridge, Massachusetts, USA).
LAF assay
IL-i biological activity was determined by the standard thymo-
cyte proliferation assay as previously described [19].
Isolation of RNA and Northern blot analysis
Macrophages (20 x 106) were seeded into 100 mm tissue
culture dishes and allowed to adhere for two hours at 37°C in a
5% C02-95% air atmosphere. After washing, macrophage mono-
layers were stimulated with 10 ng/ml LPS for four hours. Then,
cells were exposed to a lysing buffer (10 mivi Tris/HC1, pH 7.4,
containing 100 mM NaCI, 1 mMEDTA, 2% sodium dodecylsulfate
(SDS), and 250 j.g/m1 proteinase K (Sigma Chemical) for 45
minutes at 37°C. Total RNA was then extracted by the phenol-
chloroform method [20], precipitated with isopropanol and, after
dissolution in 10 mM Tris/HCI buffer, pH 7.4, containing 1 mM
EDTA, precipitated again with 3 M LiC1. After two supplementary
precipitations with ethanol, RNA concentration and purity were
determined by obtaining the A260 and A280 readings. Agarose gel
(0.9%) electrophoresis of total RNA (10 pg/lane) was followed by
Northern blot transfer on Gene Screen Plus membrane (New
England Nuclear, Boston, Massachusetts, USA).
The membranes were prehybridized for two hours at 42°C with
a solution containing 1 x Denhardt's reagent, 0.1% salmon sperm
DNA, 50% formamide, 0.5% SDS, 0.6 M NaCl, 0.005 M EDTA,
0.05 M Tris, pH 7.4. Blots were hybridized with a probe for mouse
macrophage nitric oxide synthase cDNA (mac-NOS; provided by
Dr. Charles J. Lowenstein, Johns Hopkins University, Baltimore,
Maryland, USA) [21] that was radiolabeled with dCTP [32P] (3000
Ci/mmol Amersham International, Amersham, UK) by random
primer labeling (Megaprime DNA labeling system, Amersham).
After hybridization, blots were subjected to autoradiography at
—70°C in cassettes with intensifying screens and then reprobed
with mouse f3 actin to ensure that approximately equal amounts of
RNA were loaded in each lane. Steady-state mRNA transcript
levels were quantified using scanning densitometry.
Arginase assay
Arginase activity of macrophages was measured as described by
Russel and Ruegg [22] with minor modifications [23]. Briefly, 0.25
hM L-[guanido-'4C1-arginine (53.4 mCi/mmol; NEN, Cambridge,
Massachusetts, USA) was added to the culture medium of mac-
rophages together with 300 M N'3-monomethyl-L-arginine (L-
NMMA, Sigma) and 0 to 100 ng/ml LPS. After 48 hours, 0.15 ml
of supernatant was removed and added to 0.8 ml of 250 m acetic
acid solution, pH 4.5, containing 100 m urea and 10 mM
L-arginine. After the addition of 0.3 ml of 1 g/ml Dowex resin
(HCR-W2, Sigma), the tubes were shaken for one minute and
centrifuged at 120 X g for five minutes. Five hundred microliters
of supernatant containing '4C urea were removed and added to 3
ml of Aquasafe 300 (Zinsser Analytic, Maidenhead, UK) in
counting vials. Percentage conversion of 14C-arginine to '4C-urea
was calculated as follows:
(cpm in 0.5 ml supematant) - (cpm in medium without cells)
xlOO
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Determination of constitutive NO synthase activily
Constitutive NO synthase activity was assayed indirectly by
measuring the vascular wall content of cyclic guanosine mono-
phosphate (cGMP), as previously described [24]. Rats were killed
by cervical dislocation, and thoracic aortae were rapidly excised,
rinsed in cold phosphate-buffered saline, and homogenized at 4°C
in 10 vol of 0.1 N HC1 with an all-glass homogenizer. The
homogenates were centrifuged at 15,000 X g for 15 minutes, and
supernatants were stored at —20°C until assayed. Radioimmuno-
assay of cGMP was performed after acetylation of the superna-
tants, as previously described [25].
Statistical analysis
Results are given as the mean standard error of the mean
(sEM). The statistical significance of differences between groups
was analyzed by the Student's (-test of unpaired samples. A P
value 0.05 was considered significant.
Results
The capacity of resident rat peritoneal macrophages to release
NO2- and N03 was enhanced by exposure to LPS in a dose-
dependent manner (Fig. 1). As previously shown, N02 repre-
sented in all cases about 60% of the total N02/N03 present at
the time of analysis [26].
On the basis of results obtained in comparable studies [6] w3
PUFA-supplemented diet and EFA-deficient diet were main-
tained six weeks before the capacity of macrophages to release
N02 and N03 was determined. EFA deficiency and to a lesser
extent w3 PUFA supplementation were associated with a reduc-
tion of N02 and N02/N03 release. Decrease in N02
concentration in the culture medium of macrophages stimulated
by 10 ng/ml LPS reached 57% and 37%, respectively. The .time
course of diet-induced changes in macrophage NO synthase
activity was then determined under similar conditions of stimula-
tion. Reduction in N02 release reached significance after six
weeks of o3 PUFA-supplemented diet and five weeks of EFA-
deficient diet (Fig. 2). Two weeks after the end of both diets,
NO2 levels returned to control levels.
Because LPS induces the synthesis of TNF-a and IL-i which in
turn may induce the release of NO2—, we considered the possi-
bility that the reduction of LPS-induced N02 release by modi-
fications of dietary fatty acids might reflect a decrease of TNF-a
and/or IL-i generation. First, TNF-a release into the culture
medium of macrophages was studied by bioassay. Figure 3 shows
that TNF-a bioactivity was detectable, even in the absence of LPS
challenge. At the lowest concentrations of LPS, w3 PUFA sup-
plementation and to a lesser extent EFA deficiency were associ-
ated with a reduction of TNF-a levels. To examine the relation-
ship of TNF-a to NO2 release, macrophages were stimulated
with LPS for 24 hours in the presence of neutralizing antibody to
TNF-a. This inhibited TNF-a bioactivity in the culture medium of
macrophages by >99%. As shown in Table 2, its addition did not
reduce significantly N02 release. IL-i bioactivity was not detect-
able in the culture medium of macrophages exposed to LPS
concentrations up to 10 ng/ml, ruling out the hypothesis of IL-i
involvement in NO2 release under these conditions. At a LPS
concentration of 100 ng/ml, IL-i bioactivity reached 38.6 8.8
U/mi (N = 5). Because of the unavailability of an antibody specific
Fig. 1. Production of N02 (A) and N027NO3 (B) by resident macro-
phages isolated from peritoneum after 6 weeks of control diet •), w3
PUFA-supplemented diet (a), and EPA-deficient diet (a). Cells were
incubated for 24 hours with the indicated concentrations of LPS. Means
and SEM of values obtained in 11 to 19 experiments are given. P < 0.05
vs. control diet.
for rat IL-i, we were not able to assess IL-i involvement in NO2
release under that condition.
We next determined whether diet-induced reduction of N02
generation was attributable to reduction of inducible NO synthase
mRNA levels or to other mechanisms. Macrophages stimulated
with LPS expressed detectable amounts of the inducible NO
synthase message four hours after stimulation (Fig. 4). This level
of expression was not affected by modifications of dietary fatty
acids. Another possible explanation for diet-induced reduction of
N02 generation was that the arginase pathway also present in
macrophages was increased and hence competed for substrate
with inducible NO synthase [23]. Thus we studied L-arginine
metabolism via the arginase pathway in macrophages under basal
conditions and upon exposure to LPS (Fig. 5). Basal arginase
3 4 5 6
Time, weeks weeks
after end
Fig. 2. Production of N0j resident macrophages isolated ftvrn pedto-
neum after 2 toO weeks of control diet (U), a.3 PUFA -supplemented diet ).
and EFA-deficient diet (s), and at 2 weeks after the end of dietary
manipulation. Cells were stimulated with 10 ng/ml LI'S for 24 hours.
Means and SEM of values obtained in 4 to 19 experiments are given. P C
0.05, "P < 0.005 vs. control diet.
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Table 2. TNF-a dependence for effects of LPS on N02 release from
resident macrophages
LPS nglml




* without 0.37 0.10 0.39 0.11 0.52 0.07 0.94
anti-TNF-a
antibody







* without 26.7 12.3 17.7 8.3 34.5 17.9 142.4 42.8
anti-TNF-a
antibody
* with anti- 0.0 0.0 0.0 0.0 0,2 0.1 0.9 0.9
TNF-a
antibody
Cells were incubated for 24 hours under the indicated conditions.
Means and SEM of values obtained in 6 experiments are given.
mentation increased significantly cGMP levels, whereas EFA
deficiency was inactive.
Discussion
Fig. 3. Production of bioactive TNF-a by resident macrophages isolated
from peritoneum after 6 weeks of control diet ), ca3 PUFA -supplemented
diet * and EFA -deficient diet (n). Cells were incubated for 24 hours
with the indicated concentrations of LPS. Means and SEM of values
obtained in 6 to 13 experiments are given. < 0.05 vs. control diet.
activity was present (11.8 1.0% conversion of 14C L-arginine to
14C-urea; N = 7) and was not affected by LPS. It was not increased
but, on the contrary, slightly reduced by w3 PUFA supplementa-
tion and EFA deficiency.
Finally, to dermine whether modifications of dietary fatty acids
affected both forms of NO synthase, their effect on constitutive
NO synthase activity was determined. This enzyme, located in the
endothelium, generates NO that, in turn, activates the soluble
guanylate cyclase of vascular smooth muscle, resulting in the
generation of cGMP. Thus we measured aortic cGMP levels with
a radioimmunoassay kit. Figure 6 shows that co3 PUFA supple-
The present study was designed to examine whether o3 PUFA
supplementation and EFA deficiency have significant effect on
macrophage NO generation, a parameter of immune and inflam-
matory responses. Because NO is so labile, direct measurements
of NO are difficult. Thus we measured the accumulation of
N027NO3, the major stable end products of NO. Stimulation of
resident peritoneal macrophages with LPS resulted in a time-
dependent accumulation of NO2 in the culture medium, which
reached about 2.5 nmol/105 cells at 24 hours. This value is almost
identical to that reported for the production of N02 by the
macrophage cell line J774 [27]. Examination of the effects of o3
PUFA supplementation and EFA deficiency revealed that both
dietary manipulations led to reduced release of NO21NO3 at all
the concentrations of LPS tested (Figs. 1 and 2). Because this
effect was obvious after a short-time diet (3 weeks) and was absent
two weeks after cessation of the diet, it could reflect the involve-
ment of a fast-turnover compartment of fatty acids.
The mechanisms for the diet-induced reduction of N02
release from LPS-activated macrophages are not explained by this
study. The main property both diets are known to share is the
ability to reduce arachidonic acid availability. In o3 PUFA-
supplemented diet, eicosapentaenoic acid and docosahexaenoic
acid compete with arachidonic acid as substrates for cyclooxyge-
nase and lipoxygenase and for the 2-position in membrane
phospholipids. This in turn reduces generation of prostaglandin
(PG)12, TXA2 and LTB4 [1]. In an EFA-deficient diet, dietary
restriction of linoleic acid, the arachidonic acid precursor, results
in reduced macrophage generation of PGE2, TXA2 and LTB4[28]. Because PG may contribute to favor NO synthesis in
Diets
Fig. 4. A. Inducible NO synthase mRNA levels in resident macrophages
isolated from peritoneum after 6 weeks of control diet (•), u3 PUFA-
supplemented diet (U), and EFA -deficient diet (). Cells were incubated
for 4 hours with 10 ng/ml LPS. Total RNA was isolated, and the levels of
inducible NO synthase and 13 actin mRNAs were assessed by Northern
analysis. B. Amounts of inducible NO synthase mRNA determined in five













Fig. 5. Aginase activity of resident macrophages isolated from peritoneum
after 6 weeks of control diet (U), u3 PUFA-supplemented diet (), and
EFA-deficient diet (n). Cells were incubated for 48 hours with the
indicated concentrations of LPS. Means and SEM of values obtained in 7
experiments are given. < 0.05 vs. control diet.
Fig. 6. Aortic cGMP content after 6 weeks of control diet (•), co3 PUFA-
supplemented diet (a), and EFA -deficient diet (n). Means and SEM of
values obtained in 6 experiments are given. 0.05 vs. control diet.
























response to LPS [29], their reduction may eventually account for
the decreased NO inducibility.
The mechanisms by which fatty acid dietary manipulations
affect N02 release could also involve reduction in cytokine
production, as suggested by previous works. Endres et al [11]
reported that dietary supplementation with w3 PUFA reduced
IL-i and TNF-a synthesis by stimulated human blood mononu-
clear cells. Similarly, production of IL-i and TNF-a by mononu-
clear cells was found to be significantly reduced after the con-
sumption of the low-fat, high-fish diet [30]. Data from the current
study show that decreased N02 release is associated with
reduction in TNF-a production, as assessed by measuring its
soluble and bioactive fraction (Fig. 3). It is clear from the study
with anti-TNF-a antiserum that reduction in TNF-a release and
decrease in N02 production were probably not linked. These
findings are in agreement with those reported by Zhang and
Morrison [291. These authors demonstrated that LPS stimulated
TNF-a and NO production in mouse peritoneal macrophages
through different biochemical pathways, and that the signal
transduction for both pathways was regulated by a pertussis
toxin-sensitive factor. Since TNF-a is not involved, diet-induced
reduction of N02 production could be attributed to the in-
creased production of cytokines that are inhibitory for inducible
NO synthase. They include transforming growth factor /3, IL-4 and
IL-b [31]. We are presently carrying out studies examining this
hypothesis.
Nitric oxide synthesis in macrophages is complex and involves
two successive steps that could be affected by co3 PUFA supple-
mentation and EFA deficiency. The first step is the expression of
inducible NO synthase gene. Its promoter includes various se-
quences for the binding of transcription factors such as interfer-
on-y response element and nuclear factor KB [32]. The diets
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4). The second step includes translation of the gene and expres-
sion of the enzyme in the cytosol. Fatty acid dietary manipulations
possibly reduce the level and/or the activity of this enzyme.
Because of the unavailability of an antibody specific for the
protein, we were not able to assess directly its level. But enzyme
activity has been determined indirectly. Its diet-induced reduction
could be explained by a decrease in the availability of substrate
(L-arginine) and cofactors [33]. Regarding macrophage L-argi-
nine metabolism, two pathways have been described, via NO
synthase and arginase, respectively [34]. Our results indicate that
competition of both pathways for L-arginine is not a molecular
explanation for the effect of the diets (Fig. 5). Thus the mecha-
nism by which fatty acid dietary manipulations influence macro-
phage NO generation still has to be elucidated.
The fact that no reduction in cGMP content of aortic wall was
observed after either dietary manipulation (Fig. 6) suggests that
diets affected differently the constitutive and the inducible forms
of NO synthase. Actually, w3 PUFA supplementation even in-
creased significantly constitutive NO synthase activity. This effect
is consistent with recent observation by McVeigh et al [35], who
demonstrated that fish oil supplementation significantly improved
the forearm blood flow responses to acetyicholine without altering
the responses to glycerol trinitrate in patients with type 2 diabetes
mellitus. These improved vasodilator responses have been attrib-
uted to the increased release of endothelium-derived NO.
The physiological relevance of diet-induced reduction in induc-
ible NO synthase activity is unknown. Nitric oxide has been
proposed to participate in a wide variety of functions in inflam-
matory reaction [31]. Anti-inflammatory effects are inhibition of
platelet aggregation and of leukocyte adhesion to endothelium.
Pro-inflammatory effects include vasodilation and cytotoxicity. In
fact, NO produced in nmol quantities mediates vascular relax-
ation, whereas NO produced in mmol quantities mediates cyto-
toxicity. Because following reduction of NO synthase activity by
dietary treatments, NO levels still remained in mmol range, these
diets would limit NO-induced cytotoxicity within the glomerulus
without modifying hemodynamic responses.
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